Clinical Advances in Melanoma
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Dermatology".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 1073
Special Issue Editors
Interests: melanoma; non-melanoma; general surgery; skin cancer surgery; immunotherapy; intratumoral therapy
Interests: skin and soft tissue malignancies; melanoma; nonmelanoma skin cancers; retroperitoneal and extremity sarcoma; neuroendocrine tumors
Special Issue Information
Dear Colleagues,
There has been rapid developments in melanoma science and modern immunotherapeutics in an effort to achieve the gold standard of precise, patient-tailored therapy to improve clinical outcomes and minimize toxicities associated with systemic checkpoint blockades. This Special Issue aims to provide an update for practicing clinicians with a comprehensive collection of articles and reviews.
To this end, we would like to invite original research in this area as well as state-of-the-art reviews, including reviews of emerging technologies and therapeutics, to be considered for inclusion in this issue. Examples include novel assays in development for biomarker assessment, evolving changes in relation to therapeutic timing and strategy, the best surgical practices (including post-immunotherapy patient selection, timing, and considerations for the de-escalation of surgery), the role of regional therapies in melanoma, special considerations in unique populations (such as patients with organ transplant or pregnancy status), current trends and guidelines for post-checkpoint failure treatment, the rapidly evolving application of cell therapies, and future directions in the field (including new preclinical modeling techniques and novel targets in immunotherapeutic resistance).
This Special Issue aims to present the most recent advances in the field of precision immunotherapy and their implications in the future care of melanoma patients. We look forward to your submission!
Dr. Amanda Kirane
Dr. Sarah Bateni
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- melanoma
- skin cancer surgery
- immunotherapy
- intratumoral therapy
- dermatology
